The global glycobiology market is expected to grow at a CAGR of 7.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for glycobiology products in drug discovery and development, immunology, diagnostics, and oncology applications. The increasing prevalence of chronic diseases such as diabetes mellitus type 2 and cancer are also driving the growth of this market.
The global glycobiology market by type includes reagents, instruments, kits, enzymes. Reagents segment accounted for the largest share in 2018 due to their wide range of applications in various fields such as drug discovery and development (for example antibodies), immunology (for example lectins), diagnostics (for example ELISA kits), oncology (for example monoclonal antibodies). Instruments segment accounted for the second-largest share in 2018 due to their use in various fields such as drug discovery and development (for example mass spectrometers) immunology (for example flow cytometers) diagnostics (such as PCR machines) oncology(such as confocal microscopes). Kits segment accounted for third-largest share in 2018 due to their use across various fields such as drug discovery and development(such as ELISA kits), immunology(such as ELISPOT kits), diagnostics(such as PCR kits) oncology(such like monoclonal antibody production kit). Enzymes segment accounted for fourth-largest share in 2018 due its use across various fields such as drug discovery and development(as a substrate or enzyme cofactor), immunoogy(as an enzyme cofactor or substrate), diagnostics and oncologgy.(as an enzyme cofactor or substrate).
North America region dominated the global glycobiology market with over 40% shares followed by Europe region with over 30% shares owing to high adoption rates among pharmaceutical companies located there. Asia Pacific region is expected to grow at a CAGR of 8% during forecast period owing mainly because it has been witnessing significant investments from major players into research activities related with glycoscience research which will lead towards increased demand for these products.
- The global Glycobiology market is expected to reach $3,890 million by 2022.
- Increasing prevalence of chronic diseases such as diabetes and cancer are driving the growth of the global Glycobiology market.
- Increasing research and development activities in the field of glycobiology are also driving the growth of the global Glycobiology market.
- Growing awareness about glycomics among healthcare professionals is also driving the growth of the global Glycobiology market.
Industry Growth Insights published a new data on “Glycobiology Market”. The research report is titled “Glycobiology Market research by Types (Reagents, Instruments, Kits, Enzymes), By Applications (Drug Discovery and Development, Immunology, Diagnostics, Oncology, Others), By Players/Companies Agilent Technologies, Bruker Corp, Waters Corp, Thermo Fisher Scientific, Takara Bio, Merck, Shimadzu Corp, Prozyme, New England Biolabs, Danaher Corp”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Glycobiology Market Research Report
By Type
Reagents, Instruments, Kits, Enzymes
By Application
Drug Discovery and Development, Immunology, Diagnostics, Oncology, Others
By Companies
Agilent Technologies, Bruker Corp, Waters Corp, Thermo Fisher Scientific, Takara Bio, Merck, Shimadzu Corp, Prozyme, New England Biolabs, Danaher Corp
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Glycobiology Market Report Segments:
The global Glycobiology market is segmented on the basis of:
Types
Reagents, Instruments, Kits, Enzymes
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Discovery and Development, Immunology, Diagnostics, Oncology, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agilent Technologies
- Bruker Corp
- Waters Corp
- Thermo Fisher Scientific
- Takara Bio
- Merck
- Shimadzu Corp
- Prozyme
- New England Biolabs
- Danaher Corp
Highlights of The Glycobiology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Reagents
- Instruments
- Kits
- Enzymes
- By Application:
- Drug Discovery and Development
- Immunology
- Diagnostics
- Oncology
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Glycobiology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Glycobiology is the study of glycans, which are complex carbohydrates.
Some of the key players operating in the glycobiology market are Agilent Technologies, Bruker Corp, Waters Corp, Thermo Fisher Scientific, Takara Bio, Merck, Shimadzu Corp, Prozyme, New England Biolabs, Danaher Corp.
The glycobiology market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Glycobiology Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Glycobiology Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Glycobiology Market - Supply Chain
4.5. Global Glycobiology Market Forecast
4.5.1. Glycobiology Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Glycobiology Market Size (000 Units) and Y-o-Y Growth
4.5.3. Glycobiology Market Absolute $ Opportunity
5. Global Glycobiology Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Glycobiology Market Size and Volume Forecast by Type
5.3.1. Reagents
5.3.2. Instruments
5.3.3. Kits
5.3.4. Enzymes
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Glycobiology Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Glycobiology Market Size and Volume Forecast by Application
6.3.1. Drug Discovery and Development
6.3.2. Immunology
6.3.3. Diagnostics
6.3.4. Oncology
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Glycobiology Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Glycobiology Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Glycobiology Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Glycobiology Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Glycobiology Demand Share Forecast, 2019-2026
9. North America Glycobiology Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Glycobiology Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Glycobiology Market Size and Volume Forecast by Application
9.4.1. Drug Discovery and Development
9.4.2. Immunology
9.4.3. Diagnostics
9.4.4. Oncology
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Glycobiology Market Size and Volume Forecast by Type
9.7.1. Reagents
9.7.2. Instruments
9.7.3. Kits
9.7.4. Enzymes
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Glycobiology Demand Share Forecast, 2019-2026
10. Latin America Glycobiology Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Glycobiology Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Glycobiology Market Size and Volume Forecast by Application
10.4.1. Drug Discovery and Development
10.4.2. Immunology
10.4.3. Diagnostics
10.4.4. Oncology
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Glycobiology Market Size and Volume Forecast by Type
10.7.1. Reagents
10.7.2. Instruments
10.7.3. Kits
10.7.4. Enzymes
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Glycobiology Demand Share Forecast, 2019-2026
11. Europe Glycobiology Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Glycobiology Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Glycobiology Market Size and Volume Forecast by Application
11.4.1. Drug Discovery and Development
11.4.2. Immunology
11.4.3. Diagnostics
11.4.4. Oncology
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Glycobiology Market Size and Volume Forecast by Type
11.7.1. Reagents
11.7.2. Instruments
11.7.3. Kits
11.7.4. Enzymes
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Glycobiology Demand Share, 2019-2026
12. Asia Pacific Glycobiology Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Glycobiology Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Glycobiology Market Size and Volume Forecast by Application
12.4.1. Drug Discovery and Development
12.4.2. Immunology
12.4.3. Diagnostics
12.4.4. Oncology
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Glycobiology Market Size and Volume Forecast by Type
12.7.1. Reagents
12.7.2. Instruments
12.7.3. Kits
12.7.4. Enzymes
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Glycobiology Demand Share, 2019-2026
13. Middle East & Africa Glycobiology Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Glycobiology Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Glycobiology Market Size and Volume Forecast by Application
13.4.1. Drug Discovery and Development
13.4.2. Immunology
13.4.3. Diagnostics
13.4.4. Oncology
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Glycobiology Market Size and Volume Forecast by Type
13.7.1. Reagents
13.7.2. Instruments
13.7.3. Kits
13.7.4. Enzymes
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Glycobiology Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Glycobiology Market: Market Share Analysis
14.2. Glycobiology Distributors and Customers
14.3. Glycobiology Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Agilent Technologies
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bruker Corp
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Waters Corp
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Thermo Fisher Scientific
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Takara Bio
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Merck
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Shimadzu Corp
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Prozyme
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. New England Biolabs
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Danaher Corp
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
